Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy

10Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nephrolithiasis is a known side effect of indinavir sulfate, a protease inhibitor used in the treatment of human immunodeficiency virus (HIV). The duration of its side effects, however, has not been well defined. We present a case where a patient presented with symptomatic indinavir-induced nephrolithiasis 3.5 years after discontinuing indinavir. We use this case to illustrate the pathophysiology of indinavir stones and hypothesize how they can occur years after discontinuation by discussing the pharmacokinetics of the drug. © 2010 The Author(s).

Cite

CITATION STYLE

APA

Huynh, J., Hever, A., Tom, T., & Sim, J. J. (2011). Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy. International Urology and Nephrology, 43(2), 571–573. https://doi.org/10.1007/s11255-010-9751-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free